0001578563-24-000370.txt : 20240814
0001578563-24-000370.hdr.sgml : 20240814
20240814170451
ACCESSION NUMBER: 0001578563-24-000370
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240813
FILED AS OF DATE: 20240814
DATE AS OF CHANGE: 20240814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goldman Jonathan
CENTRAL INDEX KEY: 0002013869
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37590
FILM NUMBER: 241209354
MAIL ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avalo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001534120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 450705648
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 410-522-8707
MAIL ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: Cerecor Inc.
DATE OF NAME CHANGE: 20111102
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0508
4
2024-08-13
0
0001534120
Avalo Therapeutics, Inc.
AVTX
0002013869
Goldman Jonathan
C/O AVALO THERAPEUTICS, INC.
540 GAITHER ROAD, SUITE 400
ROCKVILLE
MD
20850
1
0
0
0
0
Stock Option (Right to Buy)
9.88
2024-08-13
4
A
0
24600
0
A
2034-08-13
Common Stock
24600
24600
D
Restricted Stock Units
2024-08-13
4
A
0
9500
0
A
Common Stock
9500
9500
D
The stock option vests 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock upon the vesting date.
The RSUs vest 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date.
/s/ Donald R. Reynolds, by Power of Attorney
2024-08-14